The global market for tracheostomy products was valued at USD 192.47 million in 2021, and it is anticipated to reach USD 271 million by 2030 at a CAGR of 4.37%. A temporary or permanent medical procedure called tracheostomy entails making a hole in the patient's neck and introducing a tube into their windpipe. A slit in the neck is used to insert the tube underneath the vocal cords. As a result, fresh air can now be inhaled and breathed in. We take our breaths through the tube, as opposed to the mouth, nose, or throat. A tracheostomy is also a stoma, the name given to the neck orifice through which the tube is inserted. Patients with problems breathing because of airway obstruction, chronic lung disease, unconsciousness, or anaphylaxis, among other reasons, receive this medication. Various tracheostomy products are available, including tracheostomy tubes, cleaning kits, breathing equipment, and more. To maintain the tracheostomy (stoma) clean, the tube is inserted into the tracheostomy.
Tracheostomy tubes are available in various lengths and materials, including metal, hard plastic, and semi-flexible rubber. One or two uses are permitted for the tubes. A reusable or disposable cannula could be used for the inner cannula. Tracheostomy tubes may or may not have cuffs. Individuals who have trouble swallowing or who are on mechanical ventilation frequently utilize cuffed trach tubes. Non-cuffed trach tubes are used to keep the patient's airway open when a ventilator is unnecessary. The user's health, neck size and shape, and the purpose of the tracheostomy all affect the tube they use.
Get more information on this report Download Sample Report
The rising cases of respiratory diseases are driving the growth of the market
The rise in the number of people diagnosed with chronic respiratory conditions such as cardiovascular diseases (CVD), diabetes, respiratory diseases, cancer, and other respiratory injuries is driving the market growth. In addition, there is an ever-increasing demand for tracheostomy accessories to accommodate the expanding number of surgical procedures carried out worldwide. The leading cause of death is chronic obstructive pulmonary disease (COPD) globally. More than 251 million people worldwide were diagnosed with COPD in 2016, according to the World Health Organization. As the number of persons diagnosed with COPD rises, the demand for tracheostomy care also rises. Two key contributors to this rise in COPD prevalence are the rising prevalence of tobacco smoking and poor air quality, particularly in middle-income nations.
The rising demand for home care services and rising cases of throat cancer
The increasingly favourable scenario connected with medical payment and insurance coverage has been a driving force behind the upward trend in the industry. Although tracheostomy products make patients' lives more comfortable, they are frequently used in the home, and the growing need for in-home care has fueled this trend.
In addition, an increase in the prevalence of laryngeal or throat cancer is projected to fuel demand for products related to tracheostomy procedures. In addition, the increase in the requirement for home care and treatment services and the need for tracheostomy products are both predicted to be growth for the tracheostomy products market in the coming years. The global market for tracheostomy products will have additional opportunities to grow over the coming years as the number of patients receiving these treatments continues to rise.
Lack of knowledge about novel treatment techniques and the high cost of tracheostomy surgical treatments will hinder the market growth
The market's expansion is hampered by people's lack of knowledge about the existence of such innovative treatment devices and the high cost of tracheostomy surgical operations. A tracheostomy and related hospital stay for people without health insurance typically cost between $10,000 to $150,000 or more, depending on the need for the tracheostomy, the underlying medical condition, complications, and the length of time spent on a ventilator, and other factors. It is pretty expensive and can prevent market expansion.
The global market for tracheostomy is divided into five parts based on types, procedures, demographics, end-use and region. Further, based on type, the market is segmented into ventilation accessories, clean & care kits, and other accessories. Tracheostomy tubes are widely used in tracheostomy procedures for anaphylactic, chronic respiratory illness, coma, oesophagal cancer, laryngectomy, sleep apnea, vocal cord paralysis, and diaphragm malfunction, among other conditions. This segment dominated the market in 2021 with a share of more than 45 per cent. Significant benefits of tracheostomy tubes include enhanced ventilation, exact accuracy, less risk of emissions and aspiration, elimination of intubations, and removal of laryngoscopies.
The market has been divided into surgical and percutaneous dilatational tracheostomies based on procedures. The percutaneous dilatational tracheostomy segment dominated the market in 2021 and is anticipated to expand more quickly over the next five years. Compared to surgical methods, the percutaneous dilatational tracheostomy technique is thought to be more efficient and secure. It takes less time to complete and has a lower risk of problems.
The market has been bifurcated into an adult and paediatric/neonatal patients based on demographics. The adult patients segment led the overall market in 2021, accounting for more than 83.00 per cent of the total revenue. The rapid population expansion and rising prevalence of different chronic conditions among adults necessitating extended hospital stays were blamed for the growth.
The market is divided into hospitals and surgery centres, ambulatory care facilities, home care settings, and others based on end-use. Hospitals and surgical centres held the largest revenue share of more than 70% in 2021, dominating the global market. This expansion was related to hospitals' ability to afford expensive goods and equipment.
The market is divided into Latin America, Asia-Pacific, Europe, North America, and the Middle East & Africa. North America dominated the market in 2021.
The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Regional Growth Insights Request Sample Pages
Due to the rapid development of breakthrough technologies and therapies for throat cancer, the expanding presence of key companies in the region, and the developed healthcare infrastructure, North America dominated the market in terms of revenue share in 2021. The market expansion is also supported by essential variables such as an increase in the amount of money spent on healthcare per individual and the total number of persons who suffer from respiratory ailments. In addition, advantageous government initiatives and increased research collaborations are projected to enhance the market's growth in the North American area. The Centers for Disease Control and Prevention (CDC) estimates that in 2017, approximately 9 million persons in the United States were diagnosed with severe bronchitis.
During the time covered by this estimate, it is anticipated that the regional market in the Asia Pacific would have the highest rate of growth. The high growth rate can be linked to nations in the Asia-Pacific region with a high population density and high levels of pollution, both of which contribute to an increase in the number of cases of respiratory disorders. It is anticipated that the rapid expansion of in-home care and treatment services will also contribute to an increase in the demand for products in Asia-Pacific, which would, in turn, support the growth of the regional market throughout the projected period.